Noh HS, Kim YS, Kim YH, Han JY, Park CH, Kang AK, et al
Studies show tirzepatide achieves an average weight loss of 20.2%, compared to 13.7% for semaglutide
Individuals who have been diagnosed with pancreatitis, thyroid cancer, kidney issues, or other serious conditions linked to these medications
Typical Dosing Recommendations Ipamorelin: 100300 mcg per dose CJC-1295 with DAC: 12 mg per week (due to long half-life) Most users inject Ipamorelin 12x per day and CJC-1295 12x per week, depending on their goal (fat loss, muscle growth, recovery, etc.)
Muscle tissue acts as a glucose sink, aiding in blood sugar regulation, and provides the structural integrity necessary to prevent falls and fractures
Individuals with specific FTO variants may experience slower weight loss regardless of delivery method, while GLP1R variants can affect receptor sensitivity to the medication